NCT04769089

Brief Summary

A prospective, double blind, randomized controlled human clinical trial will be conducted by enrolling patients referred for laser treatment from the USAISR burn clinic. Laser candidates will be asked to participate who have an area of extremity or truncal scar measuring approximately 6cmX6cm total, in one contiguous region. The study sites, will consist of four equally sized treatment areas (3cm x 3cm), will be randomized to be treated with PDL, CO2, a combination of CO2+PDL, and an untreated control for 6 treatments. The areas will be photographed prior to each treatment and at the final visit 4-6 months after the last treatment. Color, pliability and thickness will be measured using a colorimeter, cutometer and high frequency ultrasound respectively at each appointment. Additionally, the Patient Observer Scar Assessment Scale (POSAS) will be used to score the quality of the scar, using two trained, blinded observers. The patients will also be asked on a voluntary basis for a pre-trial and post-trial 3mm punch biopsy to evaluate for the presence of histological changes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 19, 2017

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 24, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 24, 2020

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

February 8, 2021

Completed
16 days until next milestone

First Posted

Study publicly available on registry

February 24, 2021

Completed
Last Updated

February 24, 2021

Status Verified

February 1, 2021

Enrollment Period

2.5 years

First QC Date

February 8, 2021

Last Update Submit

February 22, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Effectiveness of laser treatments

    Using the Patient and Observer Scar Assessment Scale (POSAS), evaluate the effectiveness of Pulse Dye Laser (PDL) and Carbon Dioxide (CO2) laser treatment on symptoms related to Hypertrophic Burn Scar (HBS)

    4-6 weeks post treatment

Secondary Outcomes (1)

  • Improvement of symptoms

    4-6 weeks post treatment

Study Arms (4)

Pulse Dye Laser

EXPERIMENTAL

Treatment with PDL alone.

Procedure: Treatment with Pulse Dye Laser

CO2 Laser

EXPERIMENTAL

Treatment with CO2 alone.

Procedure: Treatment with CO2 Laser

Combination

EXPERIMENTAL

Treatment with both PDL and CO2 laser.

Procedure: Treatment with combination of pulse dye laser and CO2 laser.

No treatment

ACTIVE COMPARATOR

No laser treatment.

Other: Control

Interventions

Pulse Dye laser treatment will be applied to one randomized area with the 10mm hand piece, duration of 0.45ms, and fluence of 5.25J/s.

Pulse Dye Laser

CO2 laser treatment will be applied to one randomized area with the deep Fx hand piece, 300Hz, 15mJ, 15% density.

CO2 Laser

Pulse Dye laser and CO2 treatment will be applied to one randomized area. Pulse Dye will be applied with the 10mm hand piece, duration of 0.45ms, and fluence of 5.25J/s followed by the CO2 laser treatment with the deep Fx hand piece, 300Hz, 15mJ, 15% density.

Combination
ControlOTHER

One area will be randomized to receive no laser treatment.

No treatment

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Must have at least four areas of burn scar located on the trunk or extremities measuring 3cm x 3cm and not previously treated with laser.
  • Timing: There has been a minimum of 1 month after burn closure
  • The subject is at least 18 years of age and not older than 65.
  • Able and willing to provide verbal and written consent.

You may not qualify if:

  • Active infection in experimental area
  • Use of isotretinoin (Accutane) in last six months
  • Life or limb-threatening injury/disease
  • Prior history of non-compliance with medical regimes
  • Active drug use/abuse
  • Active psychiatric illness except depression (unless being treated for suicidal intentions)
  • Pregnancy
  • Active cancer, or new diagnosis of cancer within the past 5 years, with the exception of basal cell carcinoma, melanoma and squamous cell carcinoma, as long as the subject is disease free at the time of enrollment.
  • Prior PDL or other laser treatment of the study area.
  • Patient unable to tolerate laser procedure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

United States Army Institute of Surgical Research

Fort Sam Houston, Texas, 78234, United States

Location

Related Publications (1)

  • Cooper LE, Nuutila K, Kemp Bohan PM, Diaz V, Batchinsky M, Carlsson AH, Cancio LC, Chan RK. Analysis of the Utility of CO2 and Pulse-Dye Lasers Together and Separately in the Treatment of Hypertrophic Burn Scars. Ann Plast Surg. 2022 Aug 1;89(2):166-172. doi: 10.1097/SAP.0000000000003240.

MeSH Terms

Conditions

Cicatrix, Hypertrophic

Interventions

TherapeuticsLasers, Gas

Condition Hierarchy (Ancestors)

CicatrixFibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

LasersOptical DevicesEquipment and SuppliesRadiation Equipment and Supplies

Study Officials

  • Rodney Chan, MD

    Metis Foundation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

February 8, 2021

First Posted

February 24, 2021

Study Start

December 19, 2017

Primary Completion

June 24, 2020

Study Completion

June 24, 2020

Last Updated

February 24, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

Locations